Claris Lifesciences shares to delist on March 22
High costs of Baxter deal draw Claris investors' ire
Claris-Baxter deal may be good news for investorsNo Data Available
Claris Lifesciences Share Price
BSE
Loading...
| Open | - |
| High | - |
| Low | - |
| Prev Close | - |
| Volume | - |
| VWAP(₹) | - |
Key Metrics
| PE Ratio(x) | 1.58 |
| EPS - TTM(₹) | 250.66 |
| MCap(₹ Cr.) | 2,163.88 |
| MCap Rank | - |
| PB Ratio(x) | - |
| Div Yield(%) | 0.50 |
| Face Value(₹) | - |
| 52W High(₹) | 425.70 |
| 52W Low(₹) | 144.00 |
| MCap/Sales | - |
| Beta(1 Month) | - |
| BV/Share(₹) | - |
Claris Lifesciences Ltd. share price insights
We don’t have any Insights for this stock currently.
Claris Lifesciences Ltd. Share Price Returns
| 1 Day | 0.0% |
| 1 Month | N.A. |
| 3 Months | N.A. |
| 1 Year | N.A. |
| 3 Years | N.A. |
| 5 Years | N.A. |
Claris Lifesciences Share Recommendations
No Recommendations details available for this stock.
Check out other stock recos.
Financials
Quarterly Dec 2017 Sep 2017 Jun 2017 Mar 2017 Dec 2016 Total Income 61.48 48.46 12.64 13.73 15.66 Total Income Growth (%) 26.87 283.52 -7.95 -12.35 -92.22 Total Expenses 16.23 16.80 21.71 19.67 25.80 Total Expenses Growth (%) -3.41 -22.61 10.36 -23.74 -82.71 EBIT 45.25 31.66 -9.08 -5.95 -10.14 EBIT Growth (%) 42.95 - - - -119.46 Profit after Tax (PAT) -317.43 1,840.27 19.21 36.96 18.73 PAT Growth (%) -117.25 0.00 -48.04 97.34 -42.16 EBIT Margin (%) 73.60 65.33 -71.83 -43.33 -64.72 Net Profit Margin (%) -516.28 3,797.45 152.01 269.29 119.60 Basic EPS (₹) -58.17 337.25 3.52 6.77 3.43 No Data Available
No Data Available
No Data Available
Found Financials useful?
Technicals
No Data Available
R1 - Pivot -
S1 - R2 - S2 - R3 - S3 - 5 Days 14 Days 28 Days - - -
Peer Comparison
- 1D
- 1W
- 1M
- 3M
- 6M
- 1Y
- 5Y
Choose from Peers
Choose from Stocks
- There’s no suggested peer for this stock.
Mutual Funds Ownership
No Data Available
Claris Lifesciences Ltd. Top Searches
Corporate Actions
Board Meeting
Quarterly Results
Jan 29, 2018
General Meeting
-
Dec 27, 2017
Board Meeting
Voluntary Delisting of Shares
Dec 14, 2017
Announced on Meeting on Jan 29, 2018 Feb 06, 2018 Quarterly Results Dec 14, 2017 Dec 16, 2017 Voluntary Delisting of Shares Dec 14, 2017 Dec 06, 2017 Voluntary Delisting of Shares Nov 06, 2017 Nov 14, 2017 Quarterly Results Aug 03, 2017 Aug 11, 2017 Quarterly Results Announced on Ex-Date Dividend% May 22, 2017 Sep 11, 2017 20% May 09, 2016 Jul 21, 2016 20% Jan 07, 2014 Jan 20, 2014 90% Feb 25, 2013 Apr 04, 2013 20% Feb 29, 2012 Apr 20, 2012 20% No Data Available
No Data Available
No Data Available
Announced on Meeting on Dec 27, 2017 Jan 23, 2017 - Aug 23, 2017 Sep 19, 2017 Book closure from Sep 13, 2017 to Sep 19, 2017 Jan 17, 2017 Feb 17, 2017 - Jul 05, 2016 Jul 29, 2016 Rs.2.0000 per share(20%)Final Dividend Feb 23, 2016 Mar 25, 2016 -
About Claris Lifesciences
Industry
Key Indices Listed On
-
Address
Claris Corporate Headquarters,Near Parimal Railway Crossing,EllisbridgeAhmedabad, Gujarat - 380006
Executive Leadership
No Data Available
Auditors
No Data Available
Top Gainers
As on 03:59 PM | 23 Jun 2026Top Losers
As on 03:59 PM | 23 Jun 2026Trending in Markets
DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).
DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.
By using this site, you agree to the Terms of Service and Privacy Policy.